$SCPS: effective Dec. 19,2022 $SCPS delisted from the |
@harshgrewal |
12/16/2022 10:14:10 PM |
znewcar1: $SCPS 44% v31,4M c.3401 f21,0M pmh..6 hod.5794 then fell |
@mahermaher |
12/16/2022 4:06:11 AM |
Wonder why the spike today? |
@Sirius |
12/15/2022 1:52:19 PM |
SITC started 2 days ago November 8 and |
@7mule3 |
11/11/2022 4:00:42 AM |
NEWS SITC 2022 : |
@Germishin |
11/10/2022 11:13:00 PM |
znewcar1: $SCPS 51% v15,9M c.372 f21,1M H.51 ML.21 |
@Fain87 |
10/20/2022 3:24:42 AM |
Duet 01 Clinical Trial link here: |
@gmgaskin |
10/20/2022 2:50:51 AM |
Duet BioPharma Pipeline: |
@cgaddie1126 |
10/20/2022 2:49:51 AM |
Volume RIPPING! Nice close at .3720! |
@LMackinnon |
10/20/2022 2:16:04 AM |
Bit of a heartbeat here today ! |
@ashleyGIA |
10/20/2022 2:14:12 AM |
Home page for Duet BioTherapeutics: |
@investingfun |
10/19/2022 2:34:42 PM |
Interesting NEWS OUT! |
@RRaj |
10/18/2022 2:50:06 PM |
Oct.7/22 8K posted here re: Nasdaq compliance |
@Mrfurman32 |
10/08/2022 1:19:22 AM |
Level II TRANSLATION = we are all screwed. |
@TW8892 |
09/29/2022 7:32:21 PM |
Update on estimated trial start date August 1/22 |
@bikmedved |
09/27/2022 10:13:13 PM |
I don't think we will survive Nasdaq |
@anthonysolle123 |
09/21/2022 9:18:56 PM |
That was an outright TEASE !! |
@jrmew00 |
08/25/2022 11:23:17 PM |
Could also be further financing in the pipeline. |
@ck64220 |
08/25/2022 2:50:51 PM |
SUUMTH'INS UP, imo.!! |
@viktora |
08/25/2022 2:36:33 PM |
Delaware trial now scheduled for 2023! |
@Jlengerkin |
08/16/2022 12:23:13 AM |
Level II bid side looks interesting at the moment. |
@jorona |
08/12/2022 3:51:36 PM |
Loaded |
@sal |
07/27/2022 2:35:23 PM |
speculating - the trial is over, however the |
@Aigul |
07/20/2022 1:08:06 AM |
AH Close .45 |
@RedOakTree231 |
07/01/2022 12:44:35 AM |
CASE CLOSED - MORRIS LASTER MD, ET |
@tdzyak |
07/01/2022 12:42:27 AM |
SOMETHING IS UP!! |
@LidiyaMartin |
07/01/2022 12:41:39 AM |
Last at .42.5 (+15.87%) Volume = 152,988 |
@Crljeff |
06/17/2022 9:47:59 PM |
$SCPS - continuing on the road to Nasdaq compliance. |
@ortigoza21 |
05/27/2022 11:08:06 PM |
$SCPS - Review of Issues: |
@Mleveye |
05/22/2022 1:27:38 AM |
Departure/Letter of Paul Hopper |
@philnuke100 |
05/21/2022 10:23:53 PM |
$SCPS - Q1/2022 Financials |
@kaleb |
05/19/2022 9:41:09 PM |
Interesting Institutional Activity: |
@mr_jets |
05/16/2022 2:32:39 AM |
$SCPS - Letter from Ashish Sanghrajka |
@scale_whoop_em |
05/14/2022 6:14:58 PM |
$SCPS - Departure of Ashish Sanghrajka. |
@mmarcus25 |
05/13/2022 9:36:47 PM |
$SCPS - Nasdaq's Listing Rule 5550(a)(2) -minimum |
@nikkidog |
05/13/2022 2:06:46 AM |
$SCPS - Nasdaqs majority independent director requirement: |
@jimslulu |
05/13/2022 2:02:39 AM |
Mount Scopus |
@jpstocks303 |
05/06/2022 1:30:19 AM |
A greeting to Dr. Raphael (Rafi) Hofstein. |
@bradmill25 |
05/06/2022 1:05:40 AM |
https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-$SCPS/stock-news/880213 |
@TenkinSupertrend |
05/05/2022 3:10:18 PM |
https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-$SCPS/stock-news/88013525/current-report-fi |
@BARNONE |
05/04/2022 9:27:15 PM |
$SCPS = on track to resolution, imo. |
@Faivre |
05/02/2022 10:21:13 PM |
cont'd Delaware case |
@mortonrj |
05/02/2022 10:11:36 PM |
https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-$SCPS/stock-news/87982197/amended-annual-re |
@kmesaros |
05/02/2022 9:55:41 PM |
https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-$SCPS/stock-news/879673 |
@tomsey |
04/30/2022 2:27:36 AM |
https://www.clinicaltrials.gov/ct2/show/record/NCT04995536?term=scopus+biopharma&recrs=ab&co |
@Sohei |
04/24/2022 1:17:06 AM |
SCPS (120 days from Y/E is April 30/22) |
@Dannydong55555 |
04/24/2022 1:11:02 AM |
Answer: DUET-01 is in a Phase 1 clinical |
@VipLiveAlerts |
04/18/2022 11:58:11 PM |
Question: Chairman Messr. Lamstein, is the phase |
@conderavictor |
04/16/2022 2:43:38 AM |
Resolve the issues now please, for the greater |
@icedcffee |
04/16/2022 2:23:27 AM |
In an attempt to mitigate the dispute, reduce |
@aklekjfkla |
04/16/2022 2:10:04 AM |
13.Subsequent Events |
@testtest |
04/16/2022 2:05:27 AM |
Cash, end of period $7,942,971 |
@idronbes |
04/16/2022 1:57:41 AM |
znewcar1: SCPS 29% v6,8M c6.07 f16,8M H6.23 S@4.5 |
@Sohei |
08/05/2021 12:04:55 AM |
znewcar1: SCPS 71% v39,2M c10.25 f15,7M H19.95 S10? |
@Huyhuynh9990 |
05/24/2021 8:10:19 PM |